References

Proven Lupus Treatment By Dr Gary Levin

Proven Lupus Treatment System by Dr. Gary Levin

Get Instant Access

1. Malleson PN, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 1996; 23(11):1981-7.

2. Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Japonica 1997; 39(242):244.

3. Kaipiainen-Sappanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin Exp Rheumatol 1996; 14:441-4.

4. Cassidy JT, Sullivan DB, Petty RE, Ragsdale C. Lupus nephritis and encephalopathy Prognosis in 58 children. Arthritis Rheum 1977; 20(Suppl. 2): 315-22.

5. King KK, Kornreich HK, Bernstein BH, Singsen BH, Hanson V. The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 1977; 20(Suppl. 2):287-94.

6. Petty RE, Laxer RM. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, eds. Textbook of Pediatric Rheumatology. Philadelphia: Elsiever Saunders, 2005: 342-91.

7. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychological factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38(11):1130-7.

8. Meislin AG, Rothfield NF. Systemic lupus erythematosus in childhood: analysis of 42 cases with comparative data in 200 adult cases followed concurrently. Pediatrics 1968; 42:37-49.

9. Miettunen PM, Ortiz-Alvarez O, Petty RE, et al. Gender and ethnic origin have no effect on longterm outcome of childhood onset systemic lupus erythema-tosus. J Rheumatol 2004; 31(8):1650-4.

10. Tekano J, Tucker LB, Khattra P. Limiting obesity in children with rheumatic diseases requiring corticosteroid. Arthritis Rheum 2006; 54(Suppl. 9): Abstract.

11. Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 2000; 42(6):983-7.

12. Ghaussy NO, Sibbitt W Jr, Bankhurst AD, Qualis CR. Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 2003; 30(6): 1215-21.

13. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34(9):866-72.

14. Tucker LB, Uribe AG, Fernandez M, et al. Clinical differences between juvenile and adult onset patients with systemic lupus erythematosus (SLE): Results from a multiethnic longitudinal cohort. Arthritis Rheum 2006; 54(6):S162.

15. Carreno L, Lopez-Longo FJ, Gonzalez CM, Monteagudo I. Treatment options for juvenile-onset systemic lupus erythematosus. Pediatr Drugs 2002; 4(4): 241-56.

16. Lehman TJ. Modern treatment of childhood SLE. Clin Exp Rheumatol 2001; 19(5):487-9.

17. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 2000; 9: 401-5.

18. Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 2005; 52(9):2761-7.

19. Petri M, Kim MY, Kalunian K, et al. Combined oral contraceptives in women with systemic lupus erythematosus. New Engl J Med 2005; 353(24):2550-8.

20. Cromer BA, Scholes D, Berenson A, et al. Depot medroxyprogresterone acetate and bone mineral density in adolescents — the Black Box warning: a

Position Paper of the Society for Adolescent Medicine. J Adolesc Health 2006; 39(2):296-301.

21. Silva CA, Leal MM, Leone C, et al. Gonadal function in adolescent and young women with juvenile systemic lupus erythematosus. Lupus 2002; 11: 419-25.

22. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46(2):436-44.

23. Lacks S, White P. Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 1990; 17(7):941-5.

24. Trapani S, Civinini R, Ermini M, Paci E, Falcini F. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 1998; 18(2):45-9.

25. Rouster-Stevens KA, Klein-Gitelman M. Bone health in pediatric rheumatic disease. Curr Opin Pediatr 2005; 17(6):703-8.

26. Bruce IN. 'Not only..but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44(12):1492-502.

27. de Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M. Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus 2006; 15(10):675-82.

28. Falaschi F, Ravelli A, Martignoni A, et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2000; 43(6):1405-9.

29. Sibbitt W Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002; 29:1536-42.

30. Wyckoff PM, Miller LC, Tucker LB, Schaller JG. Neuropsychological assessment of children and adolescents with systemic lupus erythematosus. Lupus 1995; 4:217-20.

31. Steinlin MI, Blaser SI, Gilday DL, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 1995; 13(3):191-7.

32. Hagelberg S, Lee Y, Bargman J, et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002; 29(12):2635-42.

33. Walravens PA, Chase P. The prognosis of childhood systemic lupus erythematosus. Am J Dis Child 1976; 130:929-33.

34. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40(5):809-13.

35. Gladman DD, Ginzler E, Goldsmith CH, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39:363-9.

36. Bandeira M, Buratti S, Bartoli M, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006; 15:515-20.

37. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49(4):501-7.

Was this article helpful?

0 0
Nicotine Support Superstar

Nicotine Support Superstar

Stop Nicotine Addiction Is Not Easy, But You Can Do It. Discover How To Have The Best Chance Of Quitting Nicotine And Dramatically Improve Your Quality Of Your Life Today. Finally You Can Fully Equip Yourself With These Must know Blue Print To Stop Nicotine Addiction And Live An Exciting Life You Deserve!

Get My Free Ebook


Post a comment